Skip to main content

Advertisement

SpringerLink
Log in

Fibroblast heterogeneity in physiological conditions and fibrotic disease

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baragi VM, Brott DA, Qiu L, Conroy MC, Lalwani ND (1995) Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy. Lab Invest 72:484

    PubMed  CAS  Google Scholar 

  2. Bayreuther K, Rodemann HP, Hommel R, Dittmann K, Albiez M, Francz PI (1988) Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci USA 85:5112

    Article  PubMed  CAS  Google Scholar 

  3. Bordin S, Page RC, Narayanan AS (1984) Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science 223:171

    Article  PubMed  CAS  Google Scholar 

  4. Botstein GR, Sherer GK, Leroy EC (1982) Fibroblast selection in scleroderma. An alternative model of fibrosis. Arthritis Rheum 25:189

    Article  PubMed  CAS  Google Scholar 

  5. Brinckerhoff CE, Nagel JE (1981) Collagenase production by cloned populations of rabbit synovial fibroblasts. Coll Rel Res 5:433

    Google Scholar 

  6. Byron KL, Villereal ML (1989) Mitogen-induced Ca2+ changes in individual human fibroblasts. Image analysis reveals asynchronous responses which are characteristic for different mitogens. J Biol Chem 264:18234

    PubMed  CAS  Google Scholar 

  7. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103

    Article  PubMed  CAS  Google Scholar 

  8. Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56

    PubMed  CAS  Google Scholar 

  9. Desmouliere A, Rubbia-Brandt L, Abdm A, Walz T, Macieira-Coelho A, Gabbiani G (1992) α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp Cell Res 201:64

    Article  PubMed  CAS  Google Scholar 

  10. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105

    PubMed  CAS  Google Scholar 

  11. Elias JA, Rossman MD, Phillips PD (1987) Phenotypic variability among density-fractionated human lung fibroblasts. Am Rev Respir Dis 135:57

    PubMed  CAS  Google Scholar 

  12. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12:43

    Article  PubMed  CAS  Google Scholar 

  13. Falanga V, Kirsner RS (1993) Low oxygen stimulates proliferation of fibroblasts seeded as single cells. J Cell Physiol 154:506

    Article  PubMed  CAS  Google Scholar 

  14. Falanga V, Martin TA, Takagi H, Kirsner RS, Hellman T, Pardes J, Ochoa MS (1993) Low oxygen tension increases mRNA levels of αl (I) procollagen in human dermal fibroblasts. J Cell Physiol 157:408

    Article  PubMed  CAS  Google Scholar 

  15. Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB (1991) Hypoxia upregulates the synthesis of TGF-β1 by human dermal fibroblasts. J Invest Dermatol 97:634

    Article  PubMed  CAS  Google Scholar 

  16. Feghali CA, Boulware DW Ferriss JA, Levy LS (1993) Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity 16:167

    Article  PubMed  CAS  Google Scholar 

  17. Gabriella A, Di Loreto C, Taborro R, Candela M, Sambo P, Nitti C, Danieli MG, DeLustro F, Dasch JR, Danieli G (1993) Immunohistochemical localization of intracellular and extracellular associated TGF-β in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clan Immunol Immunopathol 68:340

    Article  Google Scholar 

  18. Goldring SR, Stephenson ML, Downie E, Krane SM, Korn JH (1990) Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts. J Clin Invest 85:798

    Article  PubMed  CAS  Google Scholar 

  19. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88

    Article  PubMed  CAS  Google Scholar 

  20. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C (1994) Immunocytochemical localization and serologic detection of transforming growth factor-β1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278

    Article  PubMed  CAS  Google Scholar 

  21. Jelaska A, Arakawa M, Broketa G, Korn JH (1996) Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 39:1338

    Article  PubMed  CAS  Google Scholar 

  22. Jelaska A, Korn JH (1998) Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J Cell Physiol 175:19

    Article  PubMed  CAS  Google Scholar 

  23. Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J (1986) Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem 1237:837

    Google Scholar 

  24. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse MT, Jordana G, Gauldie J (1988) Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 137:579

    PubMed  CAS  Google Scholar 

  25. Kahari V-M, Sandberg M, Kalimo H, Vuorio T, Vuorio E (1988) Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 90:664

    Article  PubMed  CAS  Google Scholar 

  26. Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M (1998) Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J Invest Dermatol 110:47

    Article  PubMed  CAS  Google Scholar 

  27. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD (1995) Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 270:3423

    Article  PubMed  CAS  Google Scholar 

  28. Korn JH (1983) Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. J Clin Invest 71:1240

    Article  PubMed  CAS  Google Scholar 

  29. Korn JH (1985) Substrain heterogeneity in prostaglandin E2 synthesis of human dermal fibroblasts. Differences in prostaglandin E2 synthetic capacity of substrains are not stimulus-restricted. Arthritis Rheum 28:315

    Article  PubMed  CAS  Google Scholar 

  30. Korn JH, Brinckerhoff CE, Edwards RL (1985) Synthesis of PGE2, collagenase and tissue factor by fibroblast substrains: substrains are differentially activated for different metabolic products. Coll Rel Res 5:437

    CAS  Google Scholar 

  31. Korn JH, Downie E (1989) Clonal interactions in fibroblast proliferation: recognition of self vs. nonself. J Cell Physiol 141:437

    Article  PubMed  CAS  Google Scholar 

  32. Korn JH, Halushka PV, LeRoy EC (1980) Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest 65:543

    Article  PubMed  CAS  Google Scholar 

  33. Korn JH, Thrall RS, Wilbur DC, Kream BE, Piela-Smith TH (1992) Fibroblast heterogeneity: clonal selection of fibroblasts as a model for fibrotic disease. In: Phipps RP (ed) Pulmonary fibroblast heterogeneity. CRC Press, Boca Raton, p 119–133

    Google Scholar 

  34. Korn JH, Torres D, Downie E (1984) Clonal heterogeneity in the fibroblast response to mononuclear cell derived mediators. Annu Rev Cell Biol 27:174

    CAS  Google Scholar 

  35. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T (1990) Co-localization of transforming growth factor-β2 with al (I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917

    Article  PubMed  CAS  Google Scholar 

  36. LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880

    Article  PubMed  CAS  Google Scholar 

  37. McDonald JA, Broekelmann TJ, Matheke ML, Crouch E, Koo M, Kuhn CD (1986) A monoclonal antibody to the carboxy-terminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest 78:1237

    Article  PubMed  CAS  Google Scholar 

  38. Mitsui Y, Schneider EL (1976) Characterization of fractionated human diploid fibroblast cell populations. Exp Cell Res 103:23

    Article  PubMed  CAS  Google Scholar 

  39. Moulin V, Castilloux G, Auger FA, Garrel D, O'Connor-McCourt MD, Germain L (1998) Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res 238:283

    Article  PubMed  CAS  Google Scholar 

  40. Needleman BW, Ordonez JV, Taramelli D, Alms W, Gayer K, Choi J (1990) In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients. Arthritis Rheum 33:842

    Article  PubMed  CAS  Google Scholar 

  41. Ohta K, Mortenson RL, Clark RA, Hirose N, King TE Jr (1995) Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152:1659

    PubMed  CAS  Google Scholar 

  42. Peltonen J, Kahari L, Jaakkola S, Kahari VM, Varga J, Uitto J, Jimenez SA (1990) Evaluation of transforming growth factor-β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol 94:365

    Article  PubMed  CAS  Google Scholar 

  43. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UL Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167

    Article  PubMed  CAS  Google Scholar 

  44. Rodemann HP, Bayreuther K, Francz PI, Dittmann K, Albiez M (1989) Selective enrichment and biochemical characterization of seven human skin fibroblasts cell types in vitro. Exp Cell Res 180:84

    Article  PubMed  CAS  Google Scholar 

  45. Rodemann HP, Muller GA (1990) Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis. Proc Soc Exp Biol Med 195:57

    PubMed  CAS  Google Scholar 

  46. Rodemann HP, Muller GA (1991) Characterization of human renal fibroblasts in health and disease. II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 17:684

    PubMed  CAS  Google Scholar 

  47. Rodemann HP, Muller GA, Knecht A, Norman JT, Fine LG (1991) Fibroblasts of rabbit kidney in culture. I. Characterization and identification of cell-specific markers. Am J Physiol 261:F283

    PubMed  CAS  Google Scholar 

  48. Scharffetter K, Lankat-Buttgereit B, Krieg T (1988) Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 18:9

    Article  PubMed  CAS  Google Scholar 

  49. Shichiri M, Sedivy JM, Marumo F, Hirata Y (1998) Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. Mol Endocrinol 12:172

    Article  PubMed  CAS  Google Scholar 

  50. Spanakis E, Brouty-Boye D (1997) Discrimination of fibroblast subtypes by multivariate analysis of gene expression. Int J Cancer 71:402

    Article  PubMed  CAS  Google Scholar 

  51. Strehlow D, Jelaska A, Strehlow K, Korn JH (1999) A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. J Clin Invest 103:1179

    Article  PubMed  CAS  Google Scholar 

  52. Tabata H, Yamakage A, Yamazaki S (1997) Cutaneous localization of endothelin 1 in patients with systemic sclerosis: immuno-electron microscopic study. Int J Dermatol 36:272

    Article  PubMed  CAS  Google Scholar 

  53. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanoh M, Ohno A, Uno Y, Minatoguchi S, Fujiwara T, Fujiwara H (1998) Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82:1130

    PubMed  CAS  Google Scholar 

  54. Tang L, Tanaka Y, Marumo F, Sato C (1994) Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 14:76

    PubMed  CAS  Google Scholar 

  55. Taylor L, Polgar P (1977) Self regulation of growth by human diploid fibroblasts via prostaglandin production. FEBS Lett 79:69

    Article  PubMed  CAS  Google Scholar 

  56. Trojanowska M, Wu LT, LeRoy EC (1988) Elevated expression of c-myc protooncogene in scleroderma fibroblasts. Oncogene 3:477

    PubMed  CAS  Google Scholar 

  57. Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor-β (TGF-β1) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs; in normal human dermal fibroblasts. Biochem J 247:597

    PubMed  CAS  Google Scholar 

  58. Worrall JG, Whiteside TL, Prince RK, Buckingham RB, Stachura I, Rodnan GP (1986) Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells. Arthritis Rheum 29:54

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Arthritis Center, Boston University School of Medicine, 715 Albany St., 02118, Boston, MA, USA

    Ante Jelaska, David Strehlow & Joseph H. Korn

Authors
  1. Ante Jelaska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Strehlow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph H. Korn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jelaska, A., Strehlow, D. & Korn, J.H. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol 21, 385–395 (2000). https://doi.org/10.1007/s002810000032

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002810000032

Keywords

Search

Navigation